Abstract
The immune system is active in breast cancer, playing a dual role in tumor progression and in immune surveillance. Infiltrating immune cells are both prognostic and predictive of response to standard breast cancer therapies.
| Original language | English (US) |
|---|---|
| Journal | ONCOLOGY (United States) |
| Volume | 29 |
| Issue number | 5 |
| State | Published - May 15 2015 |
ASJC Scopus subject areas
- Oncology
- Cancer Research